Hengrui and LSK Approved to Start US Trial of PD-1/VEGF-2 Combination

Life Science

Shanghai Miracogen Signs $125 Million Deal to Use Synaffix ADC Technologies

Life Science

China News Weekly 105 – Travel activities platform Klook raises $225M led by SoftBank’s Vision Fund

Life Science, Precious Metals, Technology

In New York, confusion reigns in the emerging CBD edibles business

Cannabis, Life Science

ReNeuron Partners with Fosun Pharma in China

Life Science

Junshi and Ascentage Partner to Test PD-1/IAP Combination

Life Science

BeiGene Enters $269 Million Agreement for BioAtla’s CTLA-4 Inhibitor

Life Science

Health care is one of Apple’s most lucrative opportunities: Morgan Stanley

Life Science

I-Mab Biopharma and Jiangsu Nhwa Pharmaceutical Announce Strategic Collaboration Agreement with Biodextris and a Boston-Based, Leading Academic Medical Center

Life Science

Digital health IPOs are finally coming to Wall Street, led by Livongo and Change Healthcare

Life Science

FDA Approves Pfizer’s Ibrance in Men With Breast Cancer

Life Science

FDA Official Tells China Biopharmas to Bring PD-1/PD-L1 Inhibitors to US

Life Science

AiLife Diagnostics and BGI Americas Partner to Provide Clinical WGS Solution

Life Science

Roivant and Sinovant Launch Cytovant Sciences in Partnership with Medigene to Develop Cellular Therapies in Asia

Life Science

Roche says its $4.3 billion offer for Spark is still on track for June completion

Life Science